188 related articles for article (PubMed ID: 31107171)
21. DMSO increases efficiency of genome editing at two non-coding loci.
Stratigopoulos G; De Rosa MC; LeDuc CA; Leibel RL; Doege CA
PLoS One; 2018; 13(6):e0198637. PubMed ID: 29864154
[TBL] [Abstract][Full Text] [Related]
22. Application of the gene editing tool, CRISPR-Cas9, for treating neurodegenerative diseases.
Kolli N; Lu M; Maiti P; Rossignol J; Dunbar GL
Neurochem Int; 2018 Jan; 112():187-196. PubMed ID: 28732771
[TBL] [Abstract][Full Text] [Related]
23.
Dandage R; Després PC; Yachie N; Landry CR
Genetics; 2019 Jun; 212(2):377-385. PubMed ID: 30936113
[TBL] [Abstract][Full Text] [Related]
24. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
[TBL] [Abstract][Full Text] [Related]
25. New Gene-Editing Tool Slowly Advances Into the Clinic.
Jenks S
J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 29117363
[No Abstract] [Full Text] [Related]
26. CRISPR-Cas9 and Its Therapeutic Applications for Retinal Diseases.
Lin WV; Stout JT; Weng CY
Int Ophthalmol Clin; 2019; 59(1):3-13. PubMed ID: 30585915
[No Abstract] [Full Text] [Related]
27. Gene Editing and Modulation: the Holy Grail for the Genetic Epilepsies?
Carpenter JC; Lignani G
Neurotherapeutics; 2021 Jul; 18(3):1515-1523. PubMed ID: 34235638
[TBL] [Abstract][Full Text] [Related]
28. Counterpoint: The Potential Harms of Human Gene Editing Using CRISPR-Cas9.
Baylis F
Clin Chem; 2018 Mar; 64(3):489-491. PubMed ID: 29490999
[No Abstract] [Full Text] [Related]
29. [CRISPR/Cas9 System and Its Advances in Gene Therapy of Hematologic Diseases--Review].
Li WY; Gao QP; Liu H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Dec; 26(6):1863-1867. PubMed ID: 30501735
[TBL] [Abstract][Full Text] [Related]
30. Genome editing: progress and challenges for medical applications.
Carroll D
Genome Med; 2016 Nov; 8(1):120. PubMed ID: 27846896
[TBL] [Abstract][Full Text] [Related]
31. Targeted Base Editing Systems Are Available for Plants.
Marzec M; Hensel G
Trends Plant Sci; 2018 Nov; 23(11):955-957. PubMed ID: 30224156
[TBL] [Abstract][Full Text] [Related]
32. Ji Luo Elucidates the CRISPR Gene Editing Technology, and How It May Affect Cancer Therapy in the Future.
Luo J
Oncology (Williston Park); 2016 Oct; 30(10):879. PubMed ID: 27753053
[No Abstract] [Full Text] [Related]
33. In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges.
Mout R; Ray M; Lee YW; Scaletti F; Rotello VM
Bioconjug Chem; 2017 Apr; 28(4):880-884. PubMed ID: 28263568
[TBL] [Abstract][Full Text] [Related]
34. Debate on Germline Gene Editing.
Cartier-Lacave N; Ali R; Ylä-Herttuala S; Kato K; Baetschi B; Lovell-Badge R; Naldini L; Thrasher A
Hum Gene Ther Methods; 2016 Aug; 27(4):135-42. PubMed ID: 27529507
[No Abstract] [Full Text] [Related]
35. Harnessing the potential of gene editing technology using CRISPR in inflammatory bowel disease.
Limanskiy V; Vyas A; Chaturvedi LS; Vyas D
World J Gastroenterol; 2019 May; 25(18):2177-2187. PubMed ID: 31143069
[TBL] [Abstract][Full Text] [Related]
36. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
Doetschman T; Georgieva T
Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
[TBL] [Abstract][Full Text] [Related]
37. CRISPR-Cas9: A revolution in genome editing in rheumatic diseases.
Duroux-Richard I; Giovannangeli C; Apparailly F
Joint Bone Spine; 2017 Jan; 84(1):1-4. PubMed ID: 27825565
[No Abstract] [Full Text] [Related]
38. CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy.
Zhang X; Wang L; Liu M; Li D
Sci China Life Sci; 2017 May; 60(5):468-475. PubMed ID: 28534255
[TBL] [Abstract][Full Text] [Related]
39. A Single Transcript CRISPR-Cas9 System for Efficient Genome Editing in Plants.
Tang X; Zheng X; Qi Y; Zhang D; Cheng Y; Tang A; Voytas DF; Zhang Y
Mol Plant; 2016 Jul; 9(7):1088-91. PubMed ID: 27212389
[No Abstract] [Full Text] [Related]
40. CRISPR 'cousin' put to the test in landmark heart-disease trial.
Ledford H
Nature; 2022 Jul; 607(7920):647. PubMed ID: 35840676
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
